FFVM
Founders Fund VII Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,773,530
| Closed | -$11.2M | – | 2 |
|
|
2024
Q2 | $11.2M | Hold |
3,773,530
| – | – | 86.9% | 1 |
|
|
2024
Q1 | $17.1M | Hold |
3,773,530
| – | – | 88.05% | 1 |
|
|
2023
Q4 | $21.5M | Hold |
3,773,530
| – | – | 89.83% | 1 |
|
|
2023
Q3 | $17.4M | Hold |
3,773,530
| – | – | 89.37% | 1 |
|
|
2023
Q2 | $24.4M | Hold |
3,773,530
| – | – | 91.35% | 1 |
|
|
2023
Q1 | $28.5M | Hold |
3,773,530
| – | – | 91.13% | 1 |
|
|
2022
Q4 | $38.2M | Hold |
3,773,530
| – | – | 94.47% | 1 |
|
|
2022
Q3 | $37.3M | Hold |
3,773,530
| – | – | 92.58% | 1 |
|
|
2022
Q2 | $40.2M | Hold |
3,773,530
| – | – | 93.02% | 1 |
|
|
2022
Q1 | $36.8M | Hold |
3,773,530
| – | – | 91.1% | 1 |
|
|
2021
Q4 | $54M | Hold |
3,773,530
| – | – | 89.75% | 1 |
|
|
2021
Q3 | $75.6M | Hold |
3,773,530
| – | – | 86.1% | 1 |
|
|
2021
Q2 | $83M | Hold |
3,773,530
| – | – | 79.6% | 1 |
|
|
2021
Q1 | $128M | Hold |
3,773,530
| – | – | 86.19% | 1 |
|
|
2020
Q4 | $152M | Buy |
+3,773,530
| New | +$152M | 85.11% | 1 |
|